Pretreatment with insulin before ischaemia reduces infarct size in Langendorff-perfused rat hearts

Acta Physiologica

Volumn 195, Issue 2, 2009, Pages 273-282

  Fuglesteg, B N ^a   Tiron, C ^b   Jonassen, A K ^b   Mjos O D ^a   Ytrehus, K ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Akt; Insulin; Ischaemia; mTOR

Indexed keywords

INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; RAPAMYCIN; TETRAZOLIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CELL CULTURE; CELL LYSATE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVATION; HEART; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; TISSUE SECTION; WESTERN BLOTTING;

ANIMALS; HYPOGLYCEMIC AGENTS; INSULIN; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MODELS, ANIMAL; MYOCARDIAL INFARCTION; ONCOGENE PROTEIN V-AKT; PERFUSION; PROTEIN KINASES; RATS; RATS, WISTAR; SIROLIMUS;

EID: 58149229482     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2008.01901.x     Document Type: Article

References (39)

1. Alessi, D.R., Deak, M., Casamayor, A., Caudwell, F.B., Morrice, N., Norman, D.G., Gaffney, P., Reese, C.B., MacDougall, C.N., Harbison, D., Ashworth, A. Bownes, M. 1997. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol 7, 776 789.
2. Apstein, C.S. Opie, L.H. 2005. A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J 26, 956 959.
3. Bell, S.P., Sack, M.N., Patel, A., Opie, L.H. Yellon, D.M. 2000. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 36, 2296 2302.
4. Bugge, E. Ytrehus, K. 1996. Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart. Cardiovasc Res 32, 920 929.
5. Claycomb, W.C., Lanson, N.A., Jr., Stallworth, B.S., Egeland, D.B., Delcaprio, J.B., Bahinski, A. Izzo, N.J., Jr. 1998. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95, 2979 2984.
6. Davidson, S.M., Hausenloy, D., Duchen, M.R. Yellon, D.M. 2006. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 38, 414 419.
7. Diaz, R., Paolasso, E.A., Piegas, L.S., Tajer, C.D., Moreno, M.G., Corvalàn, R., Isea, J.E. Romero, G. 1998. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative group. Circulation 98, 2227 2234.
8. Fath-Ordoubadi, F. Beatt, K.J. 1997. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 96, 1152 1156.
9. Garlid, K.D., Paucek, P., Yarov-Yarovoy, V., Murray, H.N., Darbenzio, R.B., D'Alonzo, A.J., Lodge, N.J., Smith, M.A. Grover, G.J. 1997. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81, 1072 1082.
10. Goto, M., Liu, Y., Yang, X.M., Ardell, J.L., Cohen, M.V. Downey, J.M. 1995. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77, 611 621.
11. Gross, G.J., Hsu, A.K. Gross, E.J. 2004. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res 94, 960 966.
12. Hausenloy, D.J., Mocanu, M.M. Yellon, D.M. 2004. Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc Res 63, 305 312.
13. Hu, Y., Qiao, L., Wang, S., Rong, S.B., Meuillet, E.J., Berggren, M., Gallegos, A., Powis, G. Kozikowski, A.P. 2000. 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. J Med Chem 43, 3045 3051.
14. Jonassen, A.K., Sack, M.N., Mjos, O.D. Yellon, D.M. 2001. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89, 1191 1198.
15. Jonassen, A.K., Mjos, O.D. Sack, M.N. 2004. p70s6 kinase is a functional target of insulin activated Akt cell-survival signaling. Biochem Biophys Res Commun 315, 160 165.
16. Juhaszova, M., Zorov, D.B., Kim, S.H., Pepe, S., Fu, Q., Fishbein, K.W., Ziman, B.D., Wang, S., Ytrehus, K., Antos, C.L., Olson, E.N. Sollott, S.J. 2004. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113, 1535 1549.
17. Kahn, S.A., Salloum, F., Das, A., Xi, L., Vetrovec, G.W. Kukreja, R.C. 2006. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol 41, 256 254.
18. Kis, A., Yellon, D.M. Baxter, G.F. 2003. Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J Mol Cell Cardiol 35, 1063 1071.
19. Lazar, H.L., Philippides, G., Fitzgerald, C., Lancaster, D., Shemin, R.J. Apstein, C. 1997. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 113, 354 360.
20. Le Good, J.A., Ziegler, W.H., Parekh, D.B., Alessi, D.R., Cohen, P. Parker, P.J. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042 2045.
21. de Leiris, J., Opie, L.H. Lubbe, W.F. 1975. Effects of free fatty acid and glucose on enzyme release in experimental myocardial infarction. Nature 253, 746 747.
22. Liu, G.S., Thornton, J., Van Winkle, D.M., Stanley, A.W., Olsson, R.A. Downey, J.M. 1991. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84, 350 356.
23. Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J.L., Bonenfant, D., Oppliger, W., Jenoe, P. Hall, M.N. 2002. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 10, 457 468.
24. Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K. Avruch, J. 2005a. Rheb binds and regulates the mTOR kinase. Curr Biol 15, 702 713.
25. Manning, B.D. 2004. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 167, 399 403.
26. Martelli, A.M., Tazzari, P.L., Tabellini, G., Bortul, R., Billi, A.M., Manzoli, L., Ruggeri, A., Conte, R. Cocco, L. 2003. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia 17, 1794 1805.
27. Mehta, S.R., Yusuf, S., Díaz, R., Zhu, J., Pais, P., Xavier, D., Paolasso, E., Ahmed, R., Xie, C., Kazmi, K., Tai, J., Orlandini, A., Pogue, J. Liu, L. 2005. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293, 437 446.
28. Mocanu, M.M., Bell, R.M. Yellon, D.M. 2002. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 34, 661 668.
29. Murphy, E. 2004. Inhibit GSK-3beta or there's heartbreak dead ahead. J Clin Invest 113, 1526 1528.
30. Murry, C.E., Jennings, R.B. Reimer, K.A. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124 1136.
31. Opie, L.H., Bruyneel, K. Owen, P. 1975. Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation 52, 49 57.
32. Sarbassov, D.D., Guertin, D.A., Ali, S.M. Sabatini, D.M. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098 1101.
33. Sodi-Pallares, D., Testelli, M.R., Fishleder, B.L., Bisteni, A., Medrano, G.A., Friedland, C. De Micheli, A. 1962. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 1967, 166 181.
34. Tong, H., Chen, W., Steenbergen, C. Murphy, E. 2000. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 87, 309 315.
35. Whitlow, P.L., Rogers, W.J., Smith, L.R., McDaniel, H.G., Papapietro, S.E., Mantle, J.A., Logic, J.R., Russell, R.O., Jr. Rackley, C.E. 1982. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol 49, 811 820.
36. Woodfield, K., Rück, A., Brdiczka, D. Halestrap, A.P. 1998. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J 336, 287 290.
37. Woodgett, J.R. 2005. Recent advances in the protein kinase B signalling pathway. Curr Opin Cell Biol 17, 150 157.
38. Wullschleger, S., Loewith, R. Hall, M.N. 2006. TOR signalling in growth and metabolism. Cell 124, 471 484.
39. Zhang, H.F., Fan, Q., Qian, X.X., Lopez, B.L., Christopher, T.A., Ma, X.L. Gao, F. 2004. Role of insulin in the anti-apoptotic effect of glucose-insulin-potassium in rabbits with acute myocardial ischemia and reperfusion. Apoptosis 9, 777 783.